Miércoles 13/05/20 Precio de los productores

[admin]

Miércoles

Eventos económicos

Precio de los productores
Habla Jeremy Powell

WEDNESDAY, MAY 13
8:30 am Producer price index April -0.5% -0.2%
9 am Fed Chair Jerome Powell speaks

[admin]

12 -60.20 -2.05
China: Shanghai Composite 2889.10 -2.46 -0.08
Japan: Nikkei 225 20279.88 -86.60 -0.43
UK: FTSE 100 5994.77 55

[admin]

-60.20 -2.05
China: Shanghai Composite 2890.98 -0.58 -0.02
Japan: Nikkei 225 20286.64 -79.84 -0.39
UK: FTSE 100 5994.77 55.04 0

[admin]

LAST CHG %CHG
Crude Oil Futures 25.57 -0.21 -0.81
Brent Crude Futures 29.45 -0.53 -1.77
Gold Futures 1707.30 0.50 0.03
Silver Futures 15.700 -0.009 -0.06
DJIA Futures 23641 67 0.28
S&P 500 Futures 2857.25 4.65 0.

[admin]

LAST CHG %CHG
Euro (EUR/USD) 1.0851 0.0001 0.01
Japanese Yen (USD/JPY) 107.17 0.03 0.03
U.K. Pound (GBP/USD) 1.2279 0.0019 0.15
Swiss Franc (USD/CHF) 0.9692 -0.0004 -0.04
Chinese Yuan (USD/CNY) 7.0910 0.0080 0.11
U.S. Dollar Index 99.97 0

[admin]

YIELD CHG
U.S. 10 Year 0.670 -0.020
Germany 10 Year -0.505 0.002
U.K. 10 Year 0.249 -0.023
Japan 10 Year -0.002 0.004
Australia 10 Year 0.955 -0.009
China 10 Year 2.666 0

[admin]

Copper May 13,01:19
Bid/Ask 2.3523 - 2.3529
Change -0.0017 -0.07%
Low/High 2.3402 - 2.3799
Charts

Nickel May 13,01:19
Bid/Ask 5.5263 - 5.5285
Change +0.0023 +0.04%
Low/High 5.4582 - 5.5648
Charts

Aluminum May 13,01:18
Bid/Ask 0.6517 - 0.6521
Change -0.0010 -0.15%
Low/High 0.6512 - 0.6593
Charts

Zinc May 13,01:19
Bid/Ask 0.8987 - 0.8992
Change -0.0036 -0.40%
Low/High 0.8960 - 0.9188
Charts

Lead May 13,01:19
Bid/Ask 0.7215 - 0.7220
Change -0.0036 -0.50%
Low/High 0.7208 - 0.7288
Charts

Uranium May 04, 2020
Ux U308 price: 33.50
Change from
previous week

[admin]

https://lta.reuters.com/articulo/econom ... O2YZ-OUSLT

[admin]

Stock futures little changed following losses from the previous session
PUBLISHED TUE, MAY 12 20206:05 PM EDTUPDATED 3 HOURS AGO
Maggie Fitzgerald
@MKMFITZGERALD
WATCH NOW
VIDEO00:48
Uber has made Grubhub a takeover offer: Sources
U.S. stock futures were little changed in overnight trading and pointed to losses at the open on Wednesday, after a sharp sell-off in the previous session.

Dow futures was up just 12 points, but implied a Wednesday opening loss of about 117 points. Futures for the S&P 500 and Nasdaq also pointed to Wednesday opening losses for the two indexes.



Stocks fell on Tuesday, after spending much of the session around the flatline, as investors parsed through the latest developments surrounding the economy reopening.

The Dow Jones Industrial Average lost more than 450 points, reversing its 160 points gain earlier in the day. The S&P 500 also registered a steep loss, dropping 2.05%.

Stocks poised to benefit from economies reopening — retail, real estate, banks and airlines — dragged down the major averages. Disney fell 3%, Nike dropped 2.9% and JPMorgan lost 3.3%. Mall operator Simon Property Group gave up a 10% gain to close in the red.

“You have a market just waiting to see how the economy opens,” Quincy Krosby, Prudential chief market strategist, told CNBC. “After nearly six sessions of the market moving higher, you’ve got the S&P 500 at an important technical level, which is 3,000, and it needs a catalyst to climb above that. One of the main catalysts will be if the economy can open up without an increase in cases.”

Chart of the three major market averages showing the Nasdaq is positive year-to-date
The Nasdaq Composite snapped its six-session winning streak on Tuesday, as investors cooled off from buying technology stocks. The average lost 2.06%; however, it just barely held its positive year-to-date gain of 0.3%. Apple and Microsoft lost 1.1% and 2.3%, respectively. Netflix fell 2% and Amazon dropped 2.2%.

Dr. Anthony Fauci said Tuesday that a vaccine will be essential in stopping the coronavirus spread, but warned it will be a while before a usable one is available. Fauci added the U.S. could face more “suffering and death” if states start to reopen too quickly.

“Even though market participants know Dr. Fauci’s stand on opening the economy too soon, to hear him testify also helped to underpin the view that if you do move too quickly you run the risk of causing cases to rise,” Krosby said.

Plus, Los Angeles County’s public health director said Tuesday the region’s stay-at-home order will “with all certainty” last through July. While several southern states have already started to let nonessential businesses resume operations.

“You also had concern regarding the U.S. China relationship and where that is heading,” Krosby added, after Sen. Lindsey Graham introduced legislation to require China to cooperate with a coronavirus investigation or face sanctions.

“Given everything that the market has to focus on, the last thing the market needs is to see the resumption of a trade war,” Krobsy added.


Traders will be looking for clarity on future Federal Reserve actions when Fed Chairman Jerome Powell speaks on current economic issues on Wednesday at 9:00 a.m. ET.

Powell’s “comments tomorrow are going to be scrutinized by the market to see how he plans thwart the issue of negative interest rates,” said Krosby.

The Labor Department will release its producer price index for the month of April at 8:30 a.m. on Wednesday. Analysts polled by Dow Jones are expecting a drop of 0.5% in April, following March’s decline of 0.2%. Producer prices have dropped during the pandemic, pulled down by declines in the costs of goods such as gasoline and services.

Sony and Cisco Systems report quarterly earnings on Wednesday.

Subscribe to CNBC PRO for exclusive insights and analysis, and live business day programming from around the

[admin]

Stock futures little changed following losses from the previous session
PUBLISHED TUE, MAY 12 20206:05 PM EDTUPDATED 3 HOURS AGO
Maggie Fitzgerald
@MKMFITZGERALD
WATCH NOW
VIDEO00:48
Uber has made Grubhub a takeover offer: Sources
U.S. stock futures were little changed in overnight trading and pointed to losses at the open on Wednesday, after a sharp sell-off in the previous session.

Dow futures was up just 12 points, but implied a Wednesday opening loss of about 117 points. Futures for the S&P 500 and Nasdaq also pointed to Wednesday opening losses for the two indexes.



Stocks fell on Tuesday, after spending much of the session around the flatline, as investors parsed through the latest developments surrounding the economy reopening.

The Dow Jones Industrial Average lost more than 450 points, reversing its 160 points gain earlier in the day. The S&P 500 also registered a steep loss, dropping 2.05%.

Stocks poised to benefit from economies reopening — retail, real estate, banks and airlines — dragged down the major averages. Disney fell 3%, Nike dropped 2.9% and JPMorgan lost 3.3%. Mall operator Simon Property Group gave up a 10% gain to close in the red.

“You have a market just waiting to see how the economy opens,” Quincy Krosby, Prudential chief market strategist, told CNBC. “After nearly six sessions of the market moving higher, you’ve got the S&P 500 at an important technical level, which is 3,000, and it needs a catalyst to climb above that. One of the main catalysts will be if the economy can open up without an increase in cases.”

Chart of the three major market averages showing the Nasdaq is positive year-to-date
The Nasdaq Composite snapped its six-session winning streak on Tuesday, as investors cooled off from buying technology stocks. The average lost 2.06%; however, it just barely held its positive year-to-date gain of 0.3%. Apple and Microsoft lost 1.1% and 2.3%, respectively. Netflix fell 2% and Amazon dropped 2.2%.

Dr. Anthony Fauci said Tuesday that a vaccine will be essential in stopping the coronavirus spread, but warned it will be a while before a usable one is available. Fauci added the U.S. could face more “suffering and death” if states start to reopen too quickly.

“Even though market participants know Dr. Fauci’s stand on opening the economy too soon, to hear him testify also helped to underpin the view that if you do move too quickly you run the risk of causing cases to rise,” Krosby said.

Plus, Los Angeles County’s public health director said Tuesday the region’s stay-at-home order will “with all certainty” last through July. While several southern states have already started to let nonessential businesses resume operations.

“You also had concern regarding the U.S. China relationship and where that is heading,” Krosby added, after Sen. Lindsey Graham introduced legislation to require China to cooperate with a coronavirus investigation or face sanctions.

“Given everything that the market has to focus on, the last thing the market needs is to see the resumption of a trade war,” Krobsy added.


Traders will be looking for clarity on future Federal Reserve actions when Fed Chairman Jerome Powell speaks on current economic issues on Wednesday at 9:00 a.m. ET.

Powell’s “comments tomorrow are going to be scrutinized by the market to see how he plans thwart the issue of negative interest rates,” said Krosby.

The Labor Department will release its producer price index for the month of April at 8:30 a.m. on Wednesday. Analysts polled by Dow Jones are expecting a drop of 0.5% in April, following March’s decline of 0.2%. Producer prices have dropped during the pandemic, pulled down by declines in the costs of goods such as gasoline and services.

Sony and Cisco Systems report quarterly earnings on Wednesday.

Subscribe to CNBC PRO for exclusive insights and analysis, and live business day programming from around the

[admin]

LAST CHG %CHG
Crude Oil Futures 25.86 0.08 0.31
Brent Crude Futures 29.93 -0.05 -0.17
Gold Futures 1709.00 2.20 0.13
Silver Futures 15.725 0.016 0.10
DJIA Futures 23718 144 0.61
S&P 500 Futures 2868

[admin]

ST CHG %CHG
Crude Oil Futures 25.91 0.13 0.50
Brent Crude Futures 29.94 -0.04 -0.13
Gold Futures 1711.50 4.70 0.28
Silver Futures 15.745 0.036 0.23
DJIA Futures 23696 122 0.52
S&P 500 Futures 2866.25 13.65 0

[admin]

Gilead strikes deal to make remdesivir coronavirus treatment in 127 countries
PUBLISHED TUE, MAY 12 20204:17 PM EDTUPDATED TUE, MAY 12 20208:32 PM EDT
Berkeley Lovelace Jr.
@BERKELEYJR
Gilead Sciences has struck a licensing agreement with five generic drugmakers to make antiviral drug remdesivir in 127 countries, not including the United States.
The deal is “royalty-free” until WHO says the Covid-19 outbreak is no longer a global health crisis or “until a pharmaceutical product other than remdesivir or a vaccine is approved to treat or prevent Covid-19.”
A lab technician visually inspects a filled vial of investigational coronavirus disease (COVID-19) treatment drug remdesivir at a Gilead Sciences facility
A lab technician visually inspects a filled vial of investigational coronavirus disease (COVID-19) treatment drug remdesivir at a Gilead Sciences facility in La Verne, California, March 11, 2020.
Gilead Sciences | via REUTERS
Gilead Sciences has struck a licensing agreement with five generic drugmakers to make antiviral drug remdesivir in 127 countries, not including the United States, the company announced Tuesday.

Drugmakers Mylan, Cipla, Ferozsons Laboratories, Hetero Labs and Jubilant Lifesciences will manufacture remdesivir for distribution in “low-income and lower-middle-income countries, as well as several upper-middle- and high-income countries” that face health-care obstacles amid the coronavirus pandemic, the company said.


The deal is “royalty-free” until the World Health Organization says the Covid-19 outbreak is no longer a global health crisis or “until a pharmaceutical product other than remdesivir or a vaccine is approved to treat or prevent Covid-19, whichever is earlier,” the company said.

WATCH NOW
VIDEO06:29
Dr. Scott Gottlieb on remdesivir rollout and US coronavirus response
The Food and Drug Administration on May 1 granted emergency use authorization for Gilead’s remdesivir drug to treat Covid-19, which has infected more than 4 million people across the globe in a little over four months, according to data compiled by Johns Hopkins University.

The intravenous drug has helped shorten the recovery time of some hospitalized Covid-19 patients, new clinical trial data suggests. Without other proven treatments, physicians will likely be considering its use to treat the coronavirus.

Gilead CEO Daniel O’Day told CNBC earlier this month that the company was working to expand its supply chain after learning from other serious outbreaks such as influenza.

The company has said it expects to produce more than 140,000 rounds of its 10-day treatment regimen by the end of this month and anticipates it can make 1 million rounds by the end of this year. Gilead said it will be able to produce “several million” rounds of its antiviral drug next year.

Here’s a list of the 127 countries that will get the drug.

[admin]

Mortgage applications from buyers jump 11%, signaling the spring housing market may not be a total loss

[admin]

Bill Gates is funding a new at-home COVID-19 testing program and it's already testing 300 people a day